StonvexLoading…
StonvexStonvexStonvexCore line items from CCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.14B | $1.01B | $758.70M | $708.84M |
Operating Income | $310.61M | $279.18M | $216.81M | $255.85M |
Net Income | $19.94M | $-179.25M | $-310.92M | $-96.60M |
EPS (Diluted) | $0.04 | $-0.37 | $-0.65 | $-0.20 |
Total Assets | $3.83B | $4.80B | $4.72B | $5.09B |
Total Liabilities | $7.22B | $8.44B | $8.17B | $8.35B |
Cash & Equivalents | $190.02M | $109.71M | $171.78M | $282.23M |
Free Cash Flow OCF − CapEx | $31.98M | $-62.65M | $-135.34M | $-44.69M |
Shares Outstanding | 495.41M | 487.65M | 481.73M | 483.54M |